Patents by Inventor Zongwen HUANG

Zongwen HUANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electronic device
    Patent number: 11968438
    Abstract: Disclosed is an electronic device including a display module and a camera module. The display module includes a first substrate and a second substrate stacked with each other, and a routing structure arranged on a surface of one side of the second substrate facing towards the first substrate, and provided with a first light-passing hole. The camera module includes a camera body and a light-shielding layer arranged on a surface of one side of the first substrate away from the second substrate and provided with a light inlet hole and a second light-passing hole. The first light-passing hole, the second light-passing hole, and the light inlet hole are arranged in an optical axis direction of the camera module. An orthographic projection of the first light-passing hole and the second light-passing hole on a surface perpendicular to the optical axis direction fall within an orthographic projection of the light inlet hole.
    Type: Grant
    Filed: May 17, 2022
    Date of Patent: April 23, 2024
    Assignee: VIVO MOBILE COMMUNICATION CO., LTD.
    Inventors: Kai Huang, Zongwen He, Huasheng Zhu, Panpan Zhu, Shangming Yang, Ling Hu
  • Use of recombinant human calcineurin B subunit
    Patent number: 10646553
    Abstract: Provided is a use of a recombinant human calcineurin B subunit (rhCNB) in the preparation of a medicine for killing and/or inhibiting the gastric cancer.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: May 12, 2020
    Assignee: HAIKOU QILI PHARMACEUTICAL CO., LTD.
    Inventors: Kesheng Han, Jian Fu, Zongwen Huang, Shuhong Tian, Lifang Han
  • USE OF RECOMBINANT HUMAN CALCINEURIN B SUBUNIT
    Publication number: 20180311320
    Abstract: Provided is a use of a recombinant human calcineurin B subunit (rhCNB) in the preparation of a medicine for killing and/or inhibiting the gastric cancer.
    Type: Application
    Filed: June 27, 2018
    Publication date: November 1, 2018
    Applicant: HAIKOU QILI PHARMACEUTICAL CO., LTD.
    Inventors: Kesheng HAN, Jian FU, Zongwen HUANG, Shuhong TIAN, Lifang HAN